CoChat

Dynamic reprogramming of DNA methylation in SETD2-deregulated renal cell carcinoma

Open access
Tiedemann, Rochelle L., Hlady, Ryan A., Hanavan, Paul D., Lake, Douglas F., Tibes, Raoul, Lee, Jeong-Heon, Choi, Jeong-Hyeon, Ho, Thai H., Robertson, Keith D. · 2016 · Oncotarget
Cited by 62

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

// Rochelle L. Tiedemann 1 , Ryan A. Hlady 2 , Paul D. Hanavan 3 , Douglas F. Lake 3 , Raoul Tibes 4,5 , Jeong-Heon Lee 5,6 , Jeong-Hyeon Choi 7 , Thai H. Ho 4,5 and Keith D. Robertson 2,5 1 Center for Epigenetics, Van Andel Research Institute, Grand Rapids, MI, USA 2 Department of Molecular Pharmacology and Experimental Therapeutics and Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA 3 School of Life Sciences, Mayo Clinic Collaborative Research Building, Arizona State University, Scottsdale, AZ, USA 4 Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA 5 Epigenomics Translational Program, Center for Individualized Medicine, Rochester, MN, USA 6 Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA 7 Department of Biostatistics, Georgia Regents University, Augusta, GA, USA Correspondence to: Thai H. Ho, email: // Keith D. Robertson, email: // Keywords : DNA methylation, epigenetics, SETD2, histone methylation, renal cell cancer Received : September 08, 2015 Accepted : November 16, 2015 Published : December 05, 2015 Abstract Clear cell renal cell carcinomas (ccRCCs) harbor frequent mutations in epigenetic modifiers including SETD2, the H3K36me3 writer. We profiled DNA methylation (5mC) across the genome in cell line-based models of SETD2 inactivation and SETD2 mutant primary tumors because 5mC has been linked to H3K36me3 and is therapeutically targetable. SETD2 depleted cell line models (long-term and acute) exhibited a DNA hypermethylation phenotype coinciding with ectopic gains in H3K36me3 centered across intergenic regions adjacent to low expressing genes, which became upregulated upon dysregulation of the epigenome. Poised enhancers of developmental genes were prominent hypermethylation targets. SETD2 mutant primary ccRCCs, papillary renal cell carcinomas, and lung adenocarcinomas all demonstrated a DNA hypermethylation phenotype that segregated tumors by SETD2 genotype and advanced grade. These findings collectively demonstrate that SETD2 mutations drive tumorigenesis by coordinated disruption of the epigenome and transcriptome,and they have important implications for future therapeutic strategies targeting chromatin regulator mutant tumors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.6481

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

Metadata

Authors
Tiedemann, R. L., Hlady, R. A., Hanavan, P. D., Lake, D. F., Tibes, R., Lee, J.-H., Choi, J.-H., Ho, T. H., & Robertson, K. D.
Venue
Oncotarget
Published
2015-12-05
Volume
7
Issue
2
Pages
1927-1946
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2280868186
Cited by
62
References
16
FWCI
2.57
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.